Thermo Fisher Scientific Inc. (TMO)
NYSE · Healthcare
Thermo Fisher Scientific Inc. Shareholder Equity 2007–2025
Thermo Fisher Scientific Inc. annual shareholder equity history from 2008 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Thermo Fisher Scientific Inc. shareholder equity as of December 31, 2025: 53.41B, a 7.71% increase year-over-year.
- Thermo Fisher Scientific Inc. shareholder equity for 2025 were 53.41B, a 7.71% increase from 2024.
- Thermo Fisher Scientific Inc. shareholder equity for 2024 were 49.58B, a 6.10% increase from 2023.
- Thermo Fisher Scientific Inc. shareholder equity for 2023 were 46.73B, a 6.27% increase from 2022.
- Thermo Fisher Scientific Inc. shareholder equity for 2022 were 43.98B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Thermo Fisher Scientific Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $53,407 |
| 2024 | $49,584 |
| 2023 | $46,735 |
| 2022 | $43,978 |
| 2021 | $40,793 |
| 2020 | $34,507 |
| 2019 | $29,675 |
| 2018 | $27,586 |
| 2017 | $25,413 |
| 2016 | $21,540 |
| 2015 | $21,350 |
| 2014 | $20,548 |
| 2013 | $16,856 |
| 2012 | $15,465 |
| 2011 | $15,038 |
Thermo Fisher Scientific Inc. Shareholder Equity — FAQ
Thermo Fisher Scientific Inc. (TMO) shareholder equity over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TMO's shareholder equity history?
The chart and table above show Thermo Fisher Scientific Inc.'s shareholder equity by year and by quarter, including the growth rate.